Clinical Trials
12 trialsNCT07315022 2026-01-02
Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University
Phase 4 Completed
NCT04785768 2025-05-22
IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration
Fujian Cancer Hospital
Phase 3 Completed
NCT04258631 2024-10-16
Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies
Mayo Clinic
Phase 4 Completed
NCT02423876 2023-09-06
Epidural Anesthesia Within an Enhanced Recovery Pathway in Reducing Pain in Patients Undergoing Gynecologic Surgery
University of Wisconsin, Madison
Phase 3 Completed
NCT02459964 2021-06-16
Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain
M.D. Anderson Cancer Center
Phase 4 Completed
NCT03375515 2021-03-08
PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain
Fujian Cancer Hospital
Phase 3 Completed
NCT00305110 2018-08-20
Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
Montefiore Medical Center
Phase 2 Completed
NCT02461056 2015-06-03
Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain
Samsung Medical Center
Phase NA Completed
NCT01824524 2014-08-15
A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer
Xian-Janssen Pharmaceutical Ltd.
Phase 1 Completed
NCT01205126 2014-02-03
An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 3 Completed
NCT00766831 2013-10-23
An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT00003115 2011-02-23
Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy
Roswell Park Cancer Institute
Phase 3 Completed